These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 10693638

  • 21. Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" study.
    Dudley C, Pohanka E, Riad H, Dedochova J, Wijngaard P, Sutter C, Silva HT, Mycophenolate Mofetil Creeping Creatinine Study Group.
    Transplantation; 2005 Feb 27; 79(4):466-75. PubMed ID: 15729174
    [Abstract] [Full Text] [Related]

  • 22. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine.
    Aleksic I, Baryalei M, Busch T, Pieske B, Schorn B, Strauch J, Sîrbu H, Dalichau H.
    Transplantation; 2000 Apr 27; 69(8):1586-90. PubMed ID: 10836367
    [Abstract] [Full Text] [Related]

  • 23. Effect of mycophenolate mofetil on kidney graft function and body weight in patients with chronic allograft nephropathy.
    Grebe SO, Mueller TF, Troeltsch M, Ebel H, Lange H.
    Transplant Proc; 2004 Dec 27; 36(10):2974-8. PubMed ID: 15686673
    [Abstract] [Full Text] [Related]

  • 24. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L, Ding T, Wang XX, Lin ZB, Chen G.
    Zhonghua Yi Xue Za Zhi; 2016 May 31; 96(20):1556-61. PubMed ID: 27266681
    [Abstract] [Full Text] [Related]

  • 25. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.
    Abramowicz D, Del Carmen Rial M, Vitko S, del Castillo D, Manas D, Lao M, Gafner N, Wijngaard P, Cyclosporine Withdrawal Study Group.
    J Am Soc Nephrol; 2005 Jul 31; 16(7):2234-40. PubMed ID: 15917338
    [Abstract] [Full Text] [Related]

  • 26. Maintenance immunosuppression with mycophenolate mofetil: long-term efficacy and safety after heart transplantation.
    Dandel M, Jasaityte R, Lehmkuhl H, Knosalla C, Hetzer R.
    Transplant Proc; 2009 Jul 31; 41(6):2585-8. PubMed ID: 19715979
    [Abstract] [Full Text] [Related]

  • 27. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.
    Yang CW, Ahn HJ, Kim WY, Li C, Kim HW, Choi BS, Cha JH, Kim YS, Kim J, Bang BK.
    Kidney Int; 2002 Jul 31; 62(1):20-30. PubMed ID: 12081560
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Randomised open clinical trial of conversion from mycophenolate mofetil to azathioprine in cadaveric renal transplantation.
    Nowacka-Cieciura E, Kamiñska B, Cieciura T, Gradowska L, Pazik J, Lao M, Rowiñski W, Paczek L.
    Transpl Int; 2000 Jul 31; 13 Suppl 1():S68-72. PubMed ID: 11111965
    [Abstract] [Full Text] [Related]

  • 30. Sirolimus attenuates the rate of progression of early chronic allograft nephropathy.
    Sumethkul V, Changsirikulchai S, Lothuvachai T, Chalermsanyakorn P.
    Transplant Proc; 2006 Dec 31; 38(10):3470-2. PubMed ID: 17175307
    [Abstract] [Full Text] [Related]

  • 31. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration.
    Meier-Kriesche HU, Steffen BJ, Hochberg AM, Gordon RD, Liebman MN, Morris JA, Kaplan B.
    Transplantation; 2003 Apr 27; 75(8):1341-6. PubMed ID: 12717227
    [Abstract] [Full Text] [Related]

  • 32. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
    Odorico JS, Pirsch JD, Knechtle SJ, D'Alessandro AM, Sollinger HW.
    Transplantation; 1998 Dec 27; 66(12):1751-9. PubMed ID: 9884272
    [Abstract] [Full Text] [Related]

  • 33. Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy.
    Gonzalez Molina M, Seron D, Garcia del Moral R, Carrera M, Sola E, Jesus Alferez M, Gomez Ullate P, Capdevila L, Gentil MA.
    Transplantation; 2004 Jan 27; 77(2):215-20. PubMed ID: 14742984
    [Abstract] [Full Text] [Related]

  • 34. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Mathew TH.
    Transplantation; 1998 Jun 15; 65(11):1450-4. PubMed ID: 9645801
    [Abstract] [Full Text] [Related]

  • 35. Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols.
    Meier-Kriesche HU, Friedman G, Jacobs M, Mulgaonkar S, Vaghela M, Kaplan B.
    Transplantation; 1999 Nov 27; 68(10):1496-502. PubMed ID: 10589946
    [Abstract] [Full Text] [Related]

  • 36. [Use of mycophenolate mofetil in patients with a transplanted kidney and cyclosporin nephrotoxicity].
    Hrvacević R, Ignjatović Lj, Vavić N, Dimitrijević J, Drasković-Pavlović B, Dujić A, Elaković D, Kronja G, Marić M.
    Vojnosanit Pregl; 2001 Nov 27; 58(2):157-60. PubMed ID: 11475669
    [Abstract] [Full Text] [Related]

  • 37. Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens.
    Citterio F, Pozzetto U, Romagnoli J, Tondolo E, Silvestri P, Nanni G, Castagneto M.
    Transplant Proc; 2004 Apr 27; 36(3):698-9. PubMed ID: 15110635
    [Abstract] [Full Text] [Related]

  • 38. Conversion to mycophenolate mofetil from azathioprine shows significant positive effect on graft function in long-term past-kidney transplantation stable-state patients.
    Nakazawa S, Kishikawa H, Kawamura M, Ueda N, Hirai T, Nishimura K.
    Transplant Proc; 2014 Apr 27; 46(2):411-4. PubMed ID: 24655976
    [Abstract] [Full Text] [Related]

  • 39. Measurement of mycophenolate mofetil effect in transplant recipients.
    Ogawa N, Nagashima N, Nakamura M, Shalabi A, Maley WR, Burdick JF.
    Transplantation; 2001 Aug 15; 72(3):422-7. PubMed ID: 11502970
    [Abstract] [Full Text] [Related]

  • 40. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.